Literature DB >> 30315441

Suppression of STAT3 by S31-201 to reduce the production of immunoinhibitory cytokines in a HIF1-α-dependent manner: a study on the MCF-7 cell line.

Amirhossein Jahangiri1, Maryam Dadmanesh2, Khodayar Ghorban3.   

Abstract

Signal transducer and activator of transcription 3 (STAT3) interacts with many gene promoters and transcription factors such as hypoxia-induced factor 1α (HIF-1α). Recent evidences proposed that STAT3 and HIF-1α together are responsible for angiogenesis and immune response suppression. The main aim of this study was to inhibit STAT3 and HIF-1α and assess their effects on the expression of immunosuppressive cytokines. S31-201 and PX-478 were used to inhibit STAT3 and HIF-1α, respectively. In both hypoxic and normoxic conditions, intracellular levels of HIF-1α were evaluated by western blotting and flow cytometry. Supernatant levels were also measured for VEGF, IL-10, and TGF-β concentration. S31-201 suppressed proliferation of MCF-7 cells and led to reduced HIF-1α expression in both hypoxic and normoxic conditions. It also decreased production of the immunosuppressive cytokines. STAT3 inhibition suppressed tumor cell growth and cytokine production in a HIF-1α-dependent manner, and can be used as a promising target in cancer therapies.

Entities:  

Keywords:  HIF-1α; IL-10; S31-201; STAT3; TGF-β; VEGF

Mesh:

Substances:

Year:  2018        PMID: 30315441     DOI: 10.1007/s11626-018-0299-6

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  2 in total

1.  Snail induces dormancy in disseminated luminal type A breast cancer through Src inhibition.

Authors:  Chun-Te Ho; Shih-Pei Lin; Ling-Ming Tseng; Mien-Chie Hung; Shih-Chieh Hung
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

2.  Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy.

Authors:  Jason V Gregory; Padma Kadiyala; Robert Doherty; Melissa Cadena; Samer Habeel; Erkki Ruoslahti; Pedro R Lowenstein; Maria G Castro; Joerg Lahann
Journal:  Nat Commun       Date:  2020-11-10       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.